Health IT Analytics February 11, 2021
The platform will help speed the development of cancer gene therapies and accelerate precision medicine in cancer care.
A team from Cleveland Clinic has developed a precision medicine platform designed to accelerate cancer gene therapies and genome-informed drug discovery.
In a study published in Nature Genetics, researchers describe the My Personal Mutanome (MPM) platform. The platform features an interactive database that offers insight into the role of somatic mutations in cancer – acquired mutations that can’t be passed to offspring – and prioritizes mutations that may be responsive to drug therapy.
“Although advances in sequencing technology have bestowed a wealth of cancer genomic data, the capabilities to bridge the translational gap between large-scale genomic studies and clinical decision making were...
Today's Sponsors
Today's Sponsor